Synergistic Effect Of Simvastatin And Romidepsin On Gamma-Globin Gene Induction
Objective Hemoglobinopathies such as beta-thalassemia and sickle cell disease (SCD) are inherited disorders that are caused by mutations in beta-globin chain. Gamma-globin gene reactivation can ameliorate clinical manifestations of beta- thalassemia and SCD. Drugs that induce fetal hemoglobin (HbF)...
Main Authors: | Hussain Habibi, Amir Atashi, Saeid Abroun, Mehrdad Noruzinia |
---|---|
Format: | Article |
Language: | English |
Published: |
Royan Institute (ACECR), Tehran
2018-08-01
|
Series: | Cell Journal |
Subjects: | |
Online Access: | https://celljournal.org/journal/article/abstract/5589 |
Similar Items
-
Simvastatin-romidepsin combination kills bladder cancer cells synergistically
by: Kazuki Okubo, et al.
Published: (2021-09-01) -
Romidepsin controls chronic lymphocytic leukemia in a patient with mycosis fungoides
by: David M. Lemchak, et al.
Published: (2016-11-01) -
Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
by: Francine Foss, et al.
Published: (2016-03-01) -
A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients
by: Cinzia Pellegrini, et al.
Published: (2016-04-01) -
Molecular mechanistic pathways underlying the anticancer therapeutic efficiency of romidepsin
by: Nasreddine El Omari, et al.
Published: (2023-08-01)